Arora P, Kempf A, Nehlmeier I, et al. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. Lancet Infect Dis 2022; published online Nov 18. https://doi.org/10.1016/S1473-3099(22)00733-2—In this Correspondence, in the figure the number above the fifth column under Pre S1–S2 should have read 679. This correction has been made to the online version as of Nov 29, 2022, and will be made to the printed version.
. 2022 Nov 29;23(2):e47. doi: 10.1016/S1473-3099(22)00804-0
Correction to Lancet Infect Dis 2022; published online Nov 18. https://doi.org/10.1016/S1473-3099(22)00733-2
Issue date 2023 Feb.
© 2022 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9708087 PMID: 36460026
This corrects the article "Omicron sublineage BQ.1.1 resistance to monoclonal antibodies" on page 22.